Immunohistochemically, PEComa typically shows positivity for melanocytic markers such as HMB45 and Melan-A, in contrast to ASPS, which remains negative for these markers [18]. The gene discussed is PMEL; the disease is neoplasm with perivascular epithelioid cell differentiation.